Physician profile
David A Cutler
NPI 1518073980
$1,187.01
in general payments reported to CMS, 2019-2025
19 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $83.88 · 2021: $87.82 · 2022: $201 · 2023: $68.36 · 2024: $278 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $321.67 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $120.81 | 2019-2025 | Lifevest |
| Pfizer INC. | $115.65 | 2019-2022 | |
| Amgen INC. | $101.35 | 2019-2020 | |
| Abiomed | $80.35 | 2020-2021 | |
| Z-Medica, LLC | $60.34 | 2019 | |
| Bridgebio Pharma, INC. | $58.86 | 2025 | Attruby |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.62 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $45.65 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $39.21 | 2019-2024 | Farxiga |
| Teleflex LLC | $35.46 | 2021-2022 | |
| Chiesi USA, INC. | $26.40 | 2019 | |
| Merck Sharp & Dohme LLC | $22.72 | 2023 | Verquvo |
| Celgene Corporation | $21.43 | 2022 | |
| Impulse Dynamics (USA) INC. | $20.50 | 2023 | Optimizer |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $19.04 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.85 | 2022 | |
| Portola Pharmaceuticals, LLC | $16.14 | 2019 | |
| Janssen Pharmaceuticals, INC | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cutler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.